Arie Belldegrun - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Allogene Therapeutics, Inc. (ALLO)

Filing Manager
Belldegrun Arie
Reporting Manager
Arie Belldegrun, M.D.
Security
Allogene Therapeutics, Inc. Common Stock
Symbol
ALLO
Shares outstanding
214M shares
Disclosed Ownership
12.4M shares
Ownership
5.8%
Form type
SCHEDULE 13G/A
Date filed
2/13/2025, 04:31 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Arie Belldegrun, M.D. 5.8% 12.4M 3.62M 8.77M /s/ Arie Belldegrun Arie Belldegrun, M.D.
Bellco Legacy LLC 0.3% 540K 0 540K /s/ Arie Belldegrun By Arie Belldegrun, M.D., Manager
Bellco Legacy IV LLC 2.2% 4.71M 0 4.71M /s/ Arie Belldegrun By Arie Belldegrun, M.D., Manager
Vida Ventures LLC 0.8% 1.8M 0 1.8M /s/ Arie Belldegrun By VV Manager LLC, its Manager, By Arie Belldegrun, M.D., Senior Managing Director,
Vida Ventures III, L.P. 0.8% 1.72M 0 1.72M /s/ Arie Belldegrun By Vida Ventures GP III, LLC, its Manager, By Arie Belldegrun, M.D., Senior Managing Director,
Vida Ventures III-A, L.P. 0% 3.97K 0 3.97K /s/ Arie Belldegrun By Vida Ventures GP III, LLC, its Manager, By Arie Belldegrun, M.D., Senior Managing Director,